Navigation Links
New marker substance for cancer cells
Date:7/5/2013

Imaging techniques in cancer medicine provide far more than merely information on the scale and location of cancerous ulcers. There are modern methods that additionally characterise the tumour cells precisely, for instance by specific molecules they carry on their surface. Such additional information gives doctors key clues as to the precise cancer type and enables them to predict the probability that a patient will respond to a particular form of therapy.

Positron emission tomography (PET) is one such technique. Unlike with computed tomography or magnetic resonance imaging, PET does not render the body tissue visible, but rather radioactively marked molecules known as tracers inside the body, which are injected into the patient's bloodstream prior to the scan. Based on the lock-and-key principle, they adhere to certain molecules on the cell surface. Through the radioactive radiation, specifically cell tissue with these surface molecules is visible on the PET scan. Researchers from ETH Zurich, the Paul Scherrer Institute and company Merck Millipore have now developed a new tracer for PET that binds to the folic acid receptor. This receptor is interesting because it accumulates on the cell surface in many cancer types. The PET scan provides information on the size and location of the tumour and the density of the folic acid receptors on the cell surface.

World's first clinical trial

The team of researchers headed by Simon Ametamey and Roger Schibli, both professors at the Institute of Pharmaceutical Sciences at ETH Zurich, have successfully tested their new substance in mice with cervical tumours. In a next step, the scientists now want to study whether the substance proves equally successful in humans. A pilot study on patients with ovarian, lung and intestinal cancer in several Swiss hospitals, including University Hospital Zurich, is in preparation. It will be the first clinical trial on a folic acid receptor marker for PET on
'/>"/>

Contact: Roger Schibli
roger.schibli@pharma.ethz.ch
41-797-801-171
ETH Zurich
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. SomaLogic publishes proteomic biomarker analysis of lung cancer tissue samples
2. New Method to Reveal Alzheimers Marker Shows Promise
3. Biomarkers can reveal IBS
4. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
5. A microRNA prognostic marker identified in acute leukemia
6. Early biomarker for pancreatic cancer identified
7. A marker in the lining of the lungs could be useful diagnostic technique for lung cancer screening
8. New biomarker test predicts arthritis at much earlier stage, MU researchers say
9. Scientists discover marker to identify, attack breast cancer stem cells
10. Biomarker predicts response to cancer treatment
11. Genetic marker may predict smoking quantity in African Americans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... PreDiabetes Centers , the pioneer in ... with a supply of sugardown®, a chewable dietary supplement ... sugar spikes. Learning how to control blood sugar levels ... a diabetes prevention plan. , Shoppers who spend $50 ... of sugardown. The offer expires November 30. , ...
(Date:10/30/2014)... By Tara Haelle ... (HealthDay News) -- More than 100 genes have been ... new studies report. And researchers say they are ... overall that may contribute to the disorder. Autism ... by communication and social difficulties and repetitive behaviors. An ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Horse ... therapeutic horseback riding to special needs individuals in the ... on Saturday, November 15 from 10-2:00 p.m. at Bailey's ... is open to the public and is designed to ... , Admission to the HSS Round-Up is free. Ticket ...
(Date:10/30/2014)... Rock Hill, South Carolina (PRWEB) October 30, 2014 ... a muscle, and should be more vigorously exercised to ... Grewal. He recently authored the book ‘Dementia Express: Lose ... , The book uses counterintuitive reasoning and sometimes conflicting ... an obstacle course for the mind, a reader must ...
(Date:10/30/2014)... comes to heart disease, a new study finds women are ... symptoms that spell trouble. "The main danger is that ... or advanced stage of heart disease, there are simply fewer ... and research fellow at the Harvard School of Public Health, ... Foundation of Canada. In the study, researchers talked to ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Women Often Ignore Signs of Heart Trouble 2
... past have argued about the implications of Hormone Replacement Therapy ... A new study, however, has gone further to show that ... developing breast cancer// if they consumed alcoholic beverages. ,The ... pattern and on whether they were on HRT currently or ...
... have found that people who take anti-depressants to relieve ... developing gastrointestinal bleeding. The study which was conducted over ... were compared for hospitalizations due to upper GI bleeding ... on selective serotonin reuptake inhibitors, or SSRIs, were 3.6-times ...
... by a Diabetes Research Centre in India has shown that ... had considerable improvement when they followed safe practices advised by ... doctors discovering that many patients came to the Centre with ... their lives. They decided that a little change in lifestyle ...
... called 'HERS' conducted by researchers of the University of California, ... that Hormone Replacement Therapy (HRT) may be able to reduce ... develop diabetes as well. ,The study involved some women ... had "impaired fasting glucose" - a condition with some ...
... 61 previous studies of blood pressure and cardiovascular disease, which ... regardless of age and even if readings are in the ... reducing risk of strokes and heart attacks. ,The study ... that out of the 120,000 who died, 56,000 suffered fatal ...
... Chairman and Managing Director of Eli Lilly and Co., India, ... cut in the company's human insulin product 'Huminsulin', that its ... market by the end of this year. He added that ... use of human insulin products and the phasing out of ...
Cached Medicine News:Health News:Women on HRT should avoid alcohol 2
(Date:10/30/2014)... 30, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, has recently released a ... is a topical liquid tetracycline-based antibiotic that uses ... convert oral medication active ingredients into topical drugs. ... aid antibiotic to help prevent skin infection in ...
(Date:10/30/2014)... 30, 2014 CVS Health (NYSE: CVS ... with three leading regional health systems to enhance access to ... systems include Baptist Health System in Alabama ... Health in Pennsylvania , Northwest Medical Center, ... and Tennova Healthcare in Tennessee ; and ...
(Date:10/30/2014)... 30, 2014 Molecular Profiles Ltd., a subsidiary ... and Maryland -based Xceleron have announced ... during clinical development that will be launched at AAPS ... This partnership extends Molecular Profiles, new ROADMAP ... earlier this month. The company also has complementary collaborations ...
Breaking Medicine Technology:ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
... Nordisk Inc., a global healthcare company and leader in diabetes care, today ... information on diabetes and chronic disease, highlighting key issues in diabetes prevention, ... , ... evolved over the last 90 years, how it is developed today, the ...
... NEW ORLEANS , July 12 Proventix Systems, Inc., of ... Alabama -based technology company, that will help them fight the spread ... , , , , ... in Infection Control and Epidemiology, HAIs contribute $28 billion to $33 ...
Cached Medicine Technology:Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease 2Proventix™ Partners with Synapse Wireless to Save Lives 2Proventix™ Partners with Synapse Wireless to Save Lives 3
... Dynal RELI™ SSO typing technique utilises a ... flank the specific target region of an ... of the resulting amplicon to an array ... a nylon membrane. The immobilisation of these ...
... The Reichert UNISTAT ... photometric analyzer for determining ... newborn infants. It quickly ... tests are needed by ...
Biotest ELPHA (=Enzyme Linked Probe Hybridization Assay) for class I and class II HLA typing shows convincing advantages for your lab routine....
... Follicle-Stimulating Hormone (FSH) is a glygoprotein produced by ... as LH, TSH, and HCG, FSH consists of ... is a solid phase direct sandwich ELISA method. ... to the wells coated with Mab to FSH ...
Medicine Products: